Science Explorer Back to mapMap

Most cited papers from Deutsches Herzzentrum der Charité

What are the most cited papers from Deutsches Herzzentrum der Charité?

The most cited paper from Deutsches Herzzentrum der Charité is "Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease" (Patrick W.J.C. Serruys, Marie‐Claude Morice, A. Pieter Kappetein et al., 2009), with 4,377 citations. Next come "A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization" (4,047) and "CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells" (2,088).

Showing 50 of 59 papers. Every paper with more than 521 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease Patrick W.J.C. Serruys, Marie‐Claude Morice, A. Pieter Kappetein et al. · New England Journal of Medicine Open access 18 Feb 2009 4,377
2 A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization Marie‐Claude Morice, Patrick W.J.C. Serruys, José Eduardo Sousa et al. · New England Journal of Medicine Open access 6 Jun 2002 4,047
3 CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells Volker Henn, Joseph R. Slupsky, Michael Gräfe et al. · Nature Feb 1998 2,088
4 Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction Volker Schächinger, Sandra Erbs, Albrecht Elsässer et al. · New England Journal of Medicine Open access 21 Sep 2006 1,896
5 Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo Marie-Luise von Brühl et al. · The Journal of Experimental Medicine Open access 26 Mar 2012 1,840
6 Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial Friedrich Wilhelm Mohr, Marie-Claude Morice, A. Pieter Kappetein et al. · The Lancet Feb 2013 1,807
7 Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI) Daniel Messroghli, James Moon, Vanessa M. Ferreira et al. · Journal of Cardiovascular Magnetic Resonance Open access Dec 2016 1,753
8 Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis Christoph David Stettler et al. · The Lancet Sep 2007 1,432
9 Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction Paul W. Armstrong, Burkert Mathias Pieske, Kevin Joseph Anstrom et al. · New England Journal of Medicine Open access 28 Mar 2020 1,350
10 Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research Philippe Généreux et al. · Journal of the American College of Cardiology Open access 19 Apr 2021 1,302
11 Myocarditis and inflammatory cardiomyopathy: current evidence and future directions Carsten Tschöpe, Enrico Ammirati, Biykem Bozkurt et al. · Nature Reviews Cardiology ReviewOpen access 12 Oct 2020 1,235
12 Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases Steffen Maßberg, Lenka Grahl, Marie‐Luise von Bruehl et al. · Nature Medicine Aug 2010 1,220
13 Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients Howard J. Eisen, Emin Murat Tuzcu, Richard Dorent et al. · New England Journal of Medicine Open access 27 Aug 2003 1,198
14 Cardioprotection and lifespan extension by the natural polyamine spermidine Tobias Eisenberg et al. · Nature Medicine Open access 14 Nov 2016 1,168
15 Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement James Moon, Daniel Messroghli, Peter Kellman et al. · Journal of Cardiovascular Magnetic Resonance Open access 2013 1,161
16 Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI Jessica L. Mega et al. · JAMA Open access 26 Oct 2010 1,142
17 Nephrotoxic Effects in High-Risk Patients Undergoing Angiography Peter Aspelin, P Aubry, Sven‐Göran Fransson et al. · New England Journal of Medicine 5 Feb 2003 1,140
18 Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal Stents Adnan Kastrati, Julinda Mehilli, Jürgen Pache et al. · New England Journal of Medicine Open access 13 Feb 2007 1,007
19 Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis Tullio Palmerini, Giuseppe Biondi‐Zoccai, Diego Della Riva et al. · The Lancet 22 Mar 2012 957
20 Intracoronary Stenting and Angiographic Results Adnan Kastrati, Julinda Mehilli, Josef Dirschinger et al. · Circulation Open access 12 Jun 2001 950
21 Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism Bernhard Meier, Bindu Kalesan, Heinrich Paul Mattle et al. · New England Journal of Medicine Open access 20 Mar 2013 928
22 Transcatheter Aortic Valve Implantation in Failed Bioprosthetic Surgical Valves Danny Dvir et al. · JAMA Open access 8 Jul 2014 921
23 Endotoxin and immune activation in chronic heart failure: a prospective cohort study Josef Niebauer, Hans‐Dieter Volk, Michael W. Kemp et al. · The Lancet May 1999 889
24 Thirty-Day Results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry Martyn Thomas, Gerhard Schymik, Thomas Walther et al. · Circulation Open access 22 Jun 2010 883
25 Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II Vasim Farooq, David V. Klaveren, Ewout Willem Steyerberg et al. · The Lancet Feb 2013 842
26 Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention Philip M. Urban et al. · Circulation Open access 22 May 2019 829
27 Mitochondrial function as a therapeutic target in heart failure David Alexander Brown, Justin B. Perry, Mitchell E. Allen et al. · Nature Reviews Cardiology ReviewOpen access 22 Dec 2016 821
28 Treatment and Prevention of Heparin-Induced Thrombocytopenia Theodore Earl Warkentin, Andreas Greinacher, Andreas Koster et al. · CHEST Journal Jun 2008 816
29 Extracorporeal Life Support in Infarct-Related Cardiogenic Shock Hölger Thiele et al. · New England Journal of Medicine Open access 26 Aug 2023 802
30 Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial Karl‐Heinz Kück, Anselm Schaumann, Lars Eckardt et al. · The Lancet 2010 801
31 Abciximab in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment The ISAR-REACT 2 Randomized Trial Adnan Kastrati · JAMA 13 Mar 2006 755
32 Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data Stuart J. Head et al. · The Lancet Open access 23 Feb 2018 751
33 Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial Gerhard Hindricks, Miloš Táborský, Michael Glikson et al. · The Lancet Aug 2014 746
34 Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials Mark Andrew Hlatky et al. · The Lancet 20 Mar 2009 745
35 Contemporary Management of Acute Right Ventricular Failure: A Statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology Veli‐Pekka Harjola et al. · European Journal of Heart Failure Mar 2016 726
36 2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease Helmut Baumgartner, Volkmar Falk, Jeroen J. Bax et al. · Revista Española de Cardiología (English Edition) Open access Feb 2018 724
37 Effects of Exercise Training on Left Ventricular Function and Peripheral Resistance in Patients With Chronic Heart Failure Rainer Hambrecht · JAMA Open access 21 Jun 2000 690
38 The Translational Landscape of the Human Heart Sebastiaan van Heesch et al. · Cell Open access 30 May 2019 688
39 Predictive Factors of Restenosis After Coronary Stent Placement Adnan Kastrati, Albert Schömig, Shpend Elezi et al. · Journal of the American College of Cardiology Open access Nov 1997 687
40 Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents Patrick W.J.C. Serruys et al. · New England Journal of Medicine Open access 16 Jun 2010 670
41 Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial Stephan Windecker, Patrick W.J.C. Serruys, Simon Wandel et al. · The Lancet Sep 2008 654
42 Assessment of the SYNTAX score in the Syntax study Patrick Serruys, Yoshinobu Onuma, Scot Garg et al. · EuroIntervention May 2009 650
43 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation Stylianos E. Tzeis et al. · EP Europace Open access 30 Mar 2024 623
44 A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents Dietmar Trenk, Gregg W. Stone, Meinrad Gawaz et al. · Journal of the American College of Cardiology Open access 19 Apr 2012 620
45 Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial Dirk Sibbing et al. · The Lancet Open access114 authors 28 Aug 2017 613
46 Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure Stephan Gielen, Volker Adams, Sven Möbius‐Winkler et al. · Journal of the American College of Cardiology Open access Sep 2003 611
47 Sirolimus-Eluting Stent or Paclitaxel-Eluting Stent vs Balloon Angioplasty for Prevention of Recurrences in Patients With Coronary In-Stent Restenosis Adnan Kastrati, Julinda Mehilli, Nicolas von Beckerath et al. · JAMA 11 Jan 2005 607
48 International Recommendations for Electrocardiographic Interpretation in Athletes Sanjay Sharma et al. · Journal of the American College of Cardiology Open access Feb 2017 603
49 Transcatheter aortic valve implantation: first results from a multi-centre real-world registry Ralf Zahn, Ulrich J. Gerckens, E. Grube et al. · European Heart Journal 23 Sep 2010 599
50 Current Treatment of In-Stent Restenosis Fernándo Alfonso, Robert A. Byrne, Fernando Rivero et al. · Journal of the American College of Cardiology Open access 16 Mar 2014 583

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.